Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass

Haven Baker1, Vyomesh Patel, Alfredo A Molinolo

  • 1Chemistry and Chemical Biology Department, Barnett Institute, Northeastern University, 341 Mugar Building, 360 Huntington Avenue, Boston, MA 02115, USA.

Oral Oncology
|February 8, 2005
PubMed

Insights

Researchers identified key proteins in head and neck squamous cell carcinomas (HNSCC) using advanced proteomic techniques. This study reveals differential protein expression, offering potential new biomarkers for HNSCC diagnosis and progression monitoring.

Area of Science:

  • Proteomics
  • Oncology
  • Molecular Biology

Background:

  • Gene expression studies in head and neck squamous cell carcinomas (HNSCC) are advancing, but protein-level data remains limited.
  • Understanding protein expression, modifications, and activity is crucial for explaining HNSCC's malignant behavior.

Purpose of the Study:

  • To identify and compare proteins in normal squamous epithelium and HNSCC using a combined proteomic approach.
  • To investigate differential protein expression and discover potential biomarkers for HNSCC.

Main Methods:

  • Combined laser-capture microdissection (LCM) with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to analyze protein fractions.
  • Analyzed protein samples from approximately 10,000-15,000 normal and tumor cells.
  • Utilized database searching to identify proteins and immunohistochemistry to validate findings.

Main Results:

  • Identified 30-55 proteins per sample, with keratins being the most abundant in both normal and tumor tissues.
  • Observed lower expression of keratin 13 in tumors compared to normal tissues.
  • Found elevated expression of heat-shock (Hsp) family members, specifically Hsp90, in HNSCC tumors.
  • Detected Wnt-6, Wnt-14, and placental growth factor (PIGF) differentially in normal and tumor tissues.

Conclusions:

  • The combined LCM and proteomic approach effectively investigates protein-level changes in HNSCC.
  • Differential protein expression, such as keratin 13 and Hsp90, highlights potential diagnostic and prognostic biomarkers.
  • This proteomic strategy complements genomic technologies and may lead to novel HNSCC biomarkers for clinical applications.